France
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
20.19%
|
Dec. 31, 2023 | USD 37.82 | -0.43% |
|
France |
|
2 |
18.33%
|
Dec. 31, 2023 | USD 125.57 | 1.43% |
|
France |
|
3 |
10.73%
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
4 |
10.58%
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
5 |
10.36%
|
Dec. 31, 2023 | USD 26.48 | -1.30% |
|
France |
|
6 |
8.80%
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
7 |
8.04%
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
8 |
7.62%
|
Dec. 31, 2023 | USD 223.78 | 0.44% |
|
France |
|
9 |
5.57%
|
Dec. 31, 2023 | USD 22.89 | 0.71% |
|
France |
|
10 |
5.05%
|
June 30, 2024 | USD 3.56 | -2.04% |
|
France |
|
11 |
3.91%
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
12 |
3.04%
|
June 30, 2024 | USD 11.08 | 0.25% |
|
France |
|
13 |
3.01%
|
Dec. 31, 2023 | USD 12.48 | 0.25% |
|
France |
|
14 |
1.78%
|
Dec. 31, 2023 | USD 2.49 | 1.52% |
|
France |
|
15 |
-8.76%
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
16 |
-12.88%
|
Dec. 31, 2023 | USD 1.58 | 0.91% |
|
France |
|
17 |
-17.65%
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
18 |
-21.01%
|
Dec. 31, 2023 | USD 3.27 | -1.63% |
|
France |
|
19 |
-25.00%
|
Dec. 31, 2023 | USD 3.21 | 17.34% |
|
France |
|
20 |
-26.75%
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
21 |
-29.13%
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
22 |
-30.25%
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
23 |
-31.56%
|
Dec. 31, 2023 | USD 1.27 | 1.92% |
|
France |
|
24 |
-33.24%
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
25 |
-52.10%
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
26 |
-53.23%
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
27 |
-62.06%
|
Dec. 31, 2023 | USD 1.61 | 2.90% |
|
France |
|
28 |
-65.62%
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
29 |
-71.77%
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
30 |
-99.27%
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
31 |
-150.69%
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
32 |
-152.84%
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
33 |
-157.45%
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
34 |
-385.63%
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
35 |
-538.93%
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
The Healthcare company in France with the highest Return on Capital Employed (ROCE) is Equasens SA (Paris Stock Exchange: EQS.PA) at 20.19%.
The Healthcare company in France with the lowest Return on Capital Employed (ROCE) is Inventiva S.A. (Paris Stock Exchange: IVA.PA) at -538.93%.
The top 10 Healthcare companies in France by Return on Capital Employed (ROCE) are Equasens SA, Ipsen S.A., Eurofins-Cerep SA, bioMérieux S.A., Boiron SA, genOway SA, Sanofi, Sartorius Stedim Biotech S.A., LNA Santé SA and Amplitude Surgical SA.
The bottom 10 Healthcare companies in France by Return on Capital Employed (ROCE) are Inventiva S.A., Adocia SA, Median Technologies SA, Advicenne S.A., AB Science S.A., MedinCell S.A., Nanobiotix S.A., MaaT Pharma SA, Cellectis S.A. and Crossject SA.